Combined chemotherapy with cisplatin, etoposide, and irinotecan versus topotecan alone as second-line treatment for patients with sensitive relapsed small-cell lung cancer (JCOG060... by Goto, Koichi, Dr, Ohe, Yuichiro, MD, Shibata, Taro, MSc, Seto, Takashi, MD, Takahashi, Toshiaki, MD, Nakagawa, Kazuhiko, Prof, Tanaka, Hiroshi, MD, Takeda, Koji, MD, Nishio, Makoto, MD, Mori, Kiyoshi, MD, Satouchi, Miyako, MD, Hida, Toyoaki, MD, Yoshimura, Naruo, MD, Kozuki, Toshiyuki, MD, Imamura, Fumio, MD, Kiura, Katsuyuki, Prof, Okamoto, Hiroaki, MD, Sawa, Toshiyuki, MD, Tamura, Tomohide, MD

Get full text

Thoracic radiotherapy with or without daily low-dose carboplatin in elderly patients with non-small-cell lung cancer: a randomised, controlled, phase 3 trial by the Japan Clinical... by Atagi, Shinji, Dr, Kawahara, Masaaki, MD, Yokoyama, Akira, MD, Okamoto, Hiroaki, MD, Yamamoto, Nobuyuki, MD, Ohe, Yuichiro, MD, Sawa, Toshiyuki, MD, Ishikura, Satoshi, MD, Shibata, Taro, MSc, Fukuda, Haruhiko, MD, Saijo, Nagahiro, MD, Tamura, Tomohide, MD

Get full text

A randomized, double-blind, phase II study of ramucirumab plus docetaxel vs placebo plus docetaxel in Japanese patients with stage IV non-small cell lung cancer after disease progr... by Kiyotaka, YOH, MD, HOSOMI, Yukio, MD, PhD, KASAHARA, Kazuo, MD, PhD, YAMADA, Kazuhiko, MD, PhD, TAKAHASHI, Toshiaki, MD, YAMAMOTO, Nobuyuki, MD, PhD, NISHIO, Makoto, MD, PhD, Yuichiro, OHE, MD, PhD, Toshiko, KOUE, PhD, NAKAMURA, Takashi, MPH, ENATSU, Sotaro, MD, PhD, Pablo, LEE, MD, FERRY, David, PhD, TAMURA, Tomohide, MD, NAKAGAWA, Kazuhiko, MD, PhD

Get full text

Etoposide and cisplatin versus irinotecan and cisplatin in patients with limited-stage small-cell lung cancer treated with etoposide and cisplatin plus concurrent accelerated hyper... by Kubota, Kaoru, Prof, Hida, Toyoaki, MD, Ishikura, Satoshi, MD, Mizusawa, Junki, MSc, Nishio, Makoto, MD, Kawahara, Masaaki, MD, Yokoyama, Akira, MD, Imamura, Fumio, MD, Takeda, Koji, MD, Negoro, Shunichi, MD, Harada, Masao, MD, Okamoto, Hiroaki, MD, Yamamoto, Nobuyuki, MD, Shinkai, Tetsu, MD, Sakai, Hiroshi, MD, Matsui, Kaoru, MD, Nakagawa, Kazuhiko, Prof, Shibata, Taro, MSc, Saijo, Nagahiro, Prof, Tamura, Tomohide, MD

Get full text

Pharmacokinetics of Weekly Paclitaxel and Feasibility of Dexamethasone Taper in Japanese Patients with Advanced Non–small Cell Lung Cancer by Nokihara, Hiroshi, MD, PhD, Yamamoto, Noboru, MD, PhD, Ohe, Yuichiro, MD, PhD, Hiraoka, Masaki, PhD, Tamura, Tomohide, MD

Get full text

Ramucirumab Plus Erlotinib Versus Placebo Plus Erlotinib in Patients With Untreated Metastatic EGFR-Mutated NSCLC: RELAY Japanese Subset by Nishio, Kazuto, Seto, Takashi, Nishio, Makoto, Reck, Martin, Garon, Edward B., Sakai, Kazuko, Goto, Koichi, Kato, Terufumi, Nakanishi, Yoichi, Takahashi, Toshiaki, Yamamoto, Nobuyuki, Kiura, Katsuyuki, Ohe, Yuichiro, Tamura, Tomohide, Visseren-Grul, Carla, Frimodt-Moller, Bente, Hozak, Rebecca R., Wijayawardana, Sameera R., Zimmermann, Annamaria, Homma, Gosuke, Enatsu, Sotaro, Nakagawa, Kazuhiko

Get full text

Efficacy and Safety of S-1 Compared With Docetaxel in Elderly Patients With Advanced NSCLC Previously Treated With Platinum-Based Chemotherapy: A Subgroup Analysis of the EAST-LC T... by Yang, James Chih-Hsin, Mok, Tony S.K., Lu, Shun, Nakagawa, Kazuhiko, Yamamoto, Nobuyuki, Shi, Yuan-Kai, Zhang, Li, Soo, Ross A., Morita, Satoshi, Tamura, Tomohide

Get full text

Alectinib versus crizotinib in patients with ALK -positive non-small-cell lung cancer (J-ALEX): an open-label, randomised phase 3 trial by Hida, Toyoaki, MD, Nokihara, Hiroshi, MD, Kondo, Masashi, MD, Kim, Young Hak, MD, Azuma, Koichi, MD, Seto, Takashi, MD, Takiguchi, Yuichi, Prof, Nishio, Makoto, MD, Yoshioka, Hiroshige, MD, Imamura, Fumio, MD, Hotta, Katsuyuki, Prof, Watanabe, Satoshi, MD, Goto, Koichi, MD, Satouchi, Miyako, MD, Kozuki, Toshiyuki, MD, Shukuya, Takehito, MD, Nakagawa, Kazuhiko, Prof, Mitsudomi, Tetsuya, Prof, Yamamoto, Nobuyuki, Prof, Asakawa, Takashi, PhD, Asabe, Ryoichi, MS, Tanaka, Tomohiro, MS, Tamura, Tomohide, Dr

Get full text

CH5424802 (RO5424802) for patients with ALK -rearranged advanced non-small-cell lung cancer (AF-001JP study): a single-arm, open-label, phase 1–2 study by Seto, Takashi, MD, Kiura, Katsuyuki, Prof, Nishio, Makoto, MD, Nakagawa, Kazuhiko, Prof, Maemondo, Makoto, MD, Inoue, Akira, MD, Hida, Toyoaki, MD, Yamamoto, Nobuyuki, MD, Yoshioka, Hiroshige, MD, Harada, Masao, MD, Ohe, Yuichiro, MD, Nogami, Naoyuki, MD, Takeuchi, Kengo, MD, Shimada, Tadashi, MS, Tanaka, Tomohiro, MS, Tamura, Tomohide, Dr

Get full text